Ongoing protein synthesis is a prerequisite in the expression of some genes. We studied the effect of various protein synthesis inhibitors on the expression of the avian metallothionein (MT) gene. Chicken embryonic hepatocytes in culture were exposed to various concentrations of cycloheximide, puromycin and pactamycin. At concentrations which decreased total protein synthesis by about 900%, each inhibitor increased MT mRNA accumulation approx. 5-fold at 9 h of incubation. Incubation with puromycin or zinc for 2 h markedly increased the rate of MT gene transcription. Estimates of the half-life of MT mRNA by using actinomycin D suggested that cycloheximide, but not puromycin, decreased the decay rate of MT mRNA. These data suggest the potential for post-transcriptional regulation of the avian MT gene. We conclude that different antibiotics increase the accumulation of hepatocyte MT mRNA by different mechanisms and that the possibility of multiple mechanisms should be considered in other studies of the role of protein synthesis in gene expression.
INTRODUCTION
Regulation of expression of the metallothionein (MT) gene has been the focus of intensive investigation. The early observation that MT induction is blocked by actinomycin D (Squibb et al., 1977) has been confirmed with new technology, and it is now clear that regulation of the MT gene occurs largely, if not exclusively, by changing the rate of transcription initiation. In fact, promoter sequences for both metal and glucocorticoid induction have been identified (Hamer, 1986) . At present research is focusing on the identification and isolation of trans-acting factors and the processes by which these factors affect transcription.
Despite a considerable knowledge of the structure of the MT promoter, the precise molecular nature of MT gene regulation is still largely unknown. An initial model (Karin & Richards, 1984) proposed that metal-free MT (thionein) was a repressor and that heavy metals stimulated transcription by removing repressor activity (derepression). This model was based largely on the finding of increased transcriptional activity and MT mRNA accumulation under conditions of decreased cellular protein synthesis (Mayo & Palmiter, 1981; Karin et al., 1980) . After that initial work, studies have indicated that 'This mechanism now seems unlikely since ... (various) analyses indicate positive rather than negative regulation' (Hamer, 1986) . Searle (1987) reached a similar conclusion, and proposed that zinc and other heavy metals activate transcription by complexing with a hypothetical metal-regulatory protein. The metal-regulatory-protein-zinc complex presumably binds, in a sequence-specific manner, to regions of the MT promoter and thereby facilitates transcription initiation. Although the metal-regulatory protein is speculative, there is increasing evidence that metal and nuclear DNA-binding factors are involved in the activation of MT gene transcription (Seguin & Hamer, 1987; Seguin & Prevost, 1988; Westin & Schaffner, 1988; Garg et al., 1989) .
In the course of experiments on the transcriptional regulation of the malic enzyme gene in chick-embryo hepatocytes, we observed that mRNA coding for MT was increased markedly under conditions of reduced protein synthesis. The simplest interpretation of these results was that a short-lived protein suppressed MT mRNA synthesis, as suggested previously by Karin & Richards (1984) . However, in view of the evidence of positive regulation of the MT gene and the observations that mRNA stability can be influenced by protein-synthesis inhibitors (Brawerman, 1989) , we investigated the mechanism by which protein-synthesis inhibitors affect MT mRNA accumulation. Our results suggest that the control of chicken hepatocyte MT mRNA levels may be mediated by both transcriptional and posttranscriptional processes.
METHODS AND MATERIALS Preparation and maintenance of isolated cells
Hepatocytes were obtained from 19-day chick embryos (Back et al., 1986) . Freshly isolated hepatocytes were suspended in serum-free Waymouth MD705/1 medium (GIBCO Laboratories) containing penicillin (60 mg/l), streptomycin (100 mg/l) and insulin (300,ug/l). Cells were incubated at 40°C (air/C02, 19: 1) in untreated 100 mm-diam. Petri dishes (diSPo; Scientific Products Co.). Cell density was approx. 2 x I07 cells/dish. Hepatocytes were maintained in culture for approx. 36 h before experimental treatments. Medium was replaced once, approx. 18 h after isolation. In the experimental incubation period, medium contained the above additions plus 3,3',5-L-triiodothyronine (1 ug/ml).
Isolation of total RNA and quantification of MT mRNA Total RNA was isolated from three plates of cells for each experimental treatment (Chomczynski & Sacchi, 1987 Vol. 273 respectively. Total RNA (10,ug) was separated by denaturing agarose (1.2 %)-gel electrophoresis (Davis et al., 1986) (Wei & Andrews, 1988) . The probe was endlabelled (Hamilton et al., 1988) and hybridized and washed by conditions described below. Membranes (10 cm x 14 cm) were prehybridized at 55°C for 4-18 h in 12 ml of 6 x SSPE (20 x SSPE = 3.6 M-NaCl, 0.2 M-sodium phosphate, 0.02 M-EDTA, pH 7.4)/i % SDS/10 x Denhardt's (100 x Denhardt's = 10 g of polyvinylpyrrolidone, lOg of BSA, lOg of Ficoll 400 and water to 500 ml)/ 100,g of denatured salmon sperm DNA/ml. Prehybridization solution was removed and replaced with hybridization solution containing 6 x SSPE/ 1 % SDS and approx. 2 x 106 c.p.m. of probe DNA/ml, and hybridized at 55°C for 24 h. Membranes were then washed three times (10 min each) at room temperature in 6 x SSPE/1 % SDS and twice (5 min each) at 55°C in 0.3 x SSPE/1 % SDS. The resulting autoradiograms were quantified by scanning densitometry (EC Apparatus), and peak areas were quantified by integration (Chromlab, Data Translation Inc.).
Measurement of transcription rates
Nuclei for transcription assays were isolated from 20 plates of hepatocytes for each treatment (Schibler et al., 1983) . Isolated nuclei were stored at -70°C in 100 ,u portions containing 50 mM-Hepes, pH 7.9, 75 mM-NaCl, 0.1 mM-EDTA, 5 mmdithiothreitol, 0.125 mM-phenylmethanesulphonyl fluoride and 50% (v/v) glycerol for no more than 1 week. The elongation reaction in vitro was conducted essentially as described by Goldman et al. (1985) . Each reaction consisted of 100 ,l of nuclei and 100 ,1 of 2 x run-on buffer [100 mM-Hepes, pH 7.9, 200 mm-KC1, 8 mM-dithiothreitol, 60 mM-EDTA, 2 mM-ATP, 1 mM-CTP, 1 mM-GTP, 4,uM-UTP, 4 mM-MnCl2, 70 mM-(NH4)2SO4, 17.6 mM-phosphocreatine, 80,ug of creatine kinase/ml], approx.
160 ,Ci of [a-32P]UTP (800 Ci/mmol; Amersham) and 30 units of RNasin (Bethesda Research Laboratories). The nuclear suspension was incubated at 26°C for 20 min, followed by addition of 1 l of 1 M-MgCl2 and 1 l of RNAase-free DNAase (11 pg/pl; Bethesda Research Laboratories). After O min incubation at room temperature, the mixture was made 1 x SET (1 % SDS, 5 mM-EDTA, 10 mM-Tris/HCl, pH 7.4), and proteinase K was added to a concentration of 250,ug/ml. After incubation at 37°C for 1 h (which occasionally was extended until the mixture clarified), the 32P-labelled RNA was purified as described by Linial et al. (1985) . The RNA was used directly in the hybridization procedure (Linial et al., 1985) using GeneScreen (New England Nuclear) containing various plasmid DNAs. Metallothionein cDNA (approx. 0.4 kb), genomic DNA (approx. 1.5 kb) and vector DNA have been described elsewhere (Wei & Andrews, 1988; Fernando & Andrews, 1989 ) and were generously provided by Dr. Glen K. Andrews, University of Kansas. Glyceraldehyde-3-phosphate dehydrogenase and /J-actin clones were kindly donated by R. Schwartz (Dugaiczyk et al., 1983) of Baylor College and D. Cleveland (Cleveland et al., 1980) of Johns Hopkins University respectively. The DNA (2 pg) probes were denatured in 0.4 M-NaOH for 10 min at room temperature, neutralized in 12 x SSC, and applied to nylon strips (GeneScreen; New England Nuclear) by using a slot-blot apparatus (Bethesda Research Laboratories). Each slot was pre-and post-washed with 6 x SSC, and membranes were dried (80°C for 1-2 h). Autoradiograms were quantified by densitometry as described above.
Hepatocyte protein synthesis Protein synthesis was evaluated by pulse-labelling the hepatocyte protein with [3H]leucine. At I h before harvest, medium was removed and replaced with a low-leucine medium (approx. 30 pMleucine) containing 10 pCi of [4,5-3H] leucine (54 Ci/mmol; ICN) per ml of medium and other additions depending on experimental treatment. After 1 h, cells were scraped off plates and collected by centrifugation. After a wash with a Ca2+-free Krebs-Ringer modified bicarbonate buffer (4.8 mM-NaCl, 120 mM-KCl, 1.2 mM-MgSO4, 1.2 mM-KH2PO4, 25 mmNaHCO3, pH 7.2) cells were homogenized in 0.5 ml of buffer (0.25 M-sucrose, 5 mM-Tris, 0.1 M-EDTA, 1 mM-dithiothreitol, pH 7.4). The homogenate was centrifuged (30 min at 10000 g at 4°C) and the supernatant collected. Samples (10 l) were applied to glass-fibre filters (2.1 cm diam.; Whatman), dried at room temperature and washed once in ice-cold 12.5 % trichloroacetic acid (30 min) and again in boiling 12.5 % trichloroacetic acid (30 min). Filters were then rinsed in 90% ethanol, dried, and radioactivity was determined by liquidscintillation counting. Total trichloroacetic acid-precipitable radioactivity was considered an estimate of protein synthesis. In preliminary experiments, the rate of [3Hlleucine incorporation was linear for 2 h. All experimental values are expressed as a percentage of the radioactivity incorporated in trichloroacetic acid-precipitable protein of control (untreated) hepatocytes.
RESULTS
Cycloheximide or puromycin for 9 h increased the concentration of MT mRNA approx. 5-fold (Fig. 1) These results probably reflect the maximum mRNA accumulation obtainable (within 9 h) with either inhibitor, since there were no differences among the various concentrations used. In other experiments, 8 pM-cycloheximide caused comparable MT mRNA accumulation, but 2 pM resulted in a clearly diminished response. At this latter concentration of cycloheximide, protein synthesis was inhibited by 83 % (results not shown). When hepatocytes were incubated with puromycin or pactamycin, protein synthesis needed to be inhibited by almost 900% before MT mRNA accumulation was detected (Fig. 2) Fig. 1) . In a separate analysis, the same RNA samples were analysed for glyceraldehyde-3-phosphate dehydrogenase mRNA as described in the legend to Fig. 1 . Neither pactamycin nor puromycin affected the abundance of that mRNA (results not shown). and the extent of accumulation of MT mRNA is related to the degree of inhibition of protein synthesis.
Protein-synthesis inhibitors could stimulate accumulation of MT mRNA by either increasing mRNA production or decreasing its degradation. We investigated both processes for puromycin and cycloheximide. Transcription run-on experiments were performed on three separate preparations of nuclei for each treatment. A zinc treatment was included in each experiment as a positive control to assure reliability of the transcription assay in vitro. The apparent transcriptional activity (assumed to reflect rate of transcription initiation) increased on average 9.5 + 3.9-and 8.2 + 4.9-fold (mean + S.E.M., n = 3) for puromycin and zinc respectively (normalized to fi-actin) (Fig. 3) . In one experiment, cycloheximide had no effect on transcriptional activity; in two others, about 3-fold increases were observed (results not shown).
Since data for the cycloheximide treatment were equivocal, an effect of this protein-synthesis inhibitor on transcriptional activation of the MT gene could not be concluded. We therefore investigated the alternative mechanism to explain increased MT mRNA accumulation, i.e. mRNA stability. MT mRNA degradation rates were determined by assessing the change in MT ii Actin GAPDH C +Zn P Fig. 3 . Effects of Zn2+ and puromycin on MT gene transcription Embryo hepatocytes were isolated as described in the Methods and materials section and the legend to Fig. 1 , and then incubated for 2 h with medium without additions (C) or a medium containing either 100/,uM-ZnCl2 (+Zn) or 250,uM-puromycin (+P). Transcription was measured in isolated nuclei by run-on assay as described in the Methods and materials section. For each treatment, 2 x 107 c.p.m. of labelled nuclear RNA was hybridized with membranes containing 2 ,g each of the indicated DNAs (abbreviation: GAPDH, glyceraldehyde-3-phosphate dehydrogenase). After 4 days of hybridization, the membranes were washed and exposed to X-ray film at -70 'C. Blots were scanned by densitometry and quantified by integration. Values obtained with genomic MT were normalized to | 6-actin and expressed as a percentage of control (see the Results section). In contrast, the presence of puromycin had little or no effect on the rate of MT mRNA degradation. These data support a role for post-transcriptional regulation in the elevation of MT mRNA levels caused by cycloheximide. To our knowledge, this is the first report of experimentally induced changes in MT mRNA stability. Owing to the variable results with cycloheximide in the run-on experiments, we cannot formally eliminate an effect of cycloheximide on transcriptional activation. It would appear, however, that a major portion of the.effect of cycloheximide on MT mRNA accumulation is due to increased mRNA stability.
DISCUSSION
Protein-synthesis inhibitors increase MT mRNA in chicken hepatocytes by two different mechanisms. Puromycin significantly increased rates of transcription, but had little or no effect on mRNA stability. Cycloheximide, on the other hand, stabilized MT mRNA, but had little consistent effect on transcription. These differences could be due to relative abilities of the antibiotics to inhibit protein synthesis. On average, cycloheximide inhibited protein synthesis by no more than 92 %, even at the higher concentrations. Puromycin was consistently more potent, inhibiting by 97-98 % at the higher concentrations. It was these higher concentrations that were used in the transcription experiments. Others have noted that cycloheximide is less potent than other antibiotics in blocking protein synthesis (Greenberg et al., 1986) . Thus the contrasting effects obtained with cycloheximide Vol. 273 heximide (+ CHX) Embryo hepatocytes were prepared as described in the Methods and materials section and the legend to Fig. 1 and puromycin on transcriptional activity of the MT gene may, in part, be explained by the greater ability of puromycin to inhibit protein synthesis. It is clear from data shown in Fig. 2(a) that relatively small changes in protein synthesis, i.e. that occurring between 63 /tM-and 32 /aM-puromycin (88 % to 81 % inhibition), result in marked differences in MT mRNA accumulation.
The most perplexing result of the present study was the inability of cycloheximide to increase consistently the transcription of the MT gene. Several groups have reported that cycloheximide increases accumulation hepatic MT mRNA (Karin et al., 1980; Mayo & Palmiter, 1981; Imbra & Karin, 1987; McCormick & Fleet, 1989 ), but few have attempted to assess the mechanism. In mouse sarcoma cells treated with cycloheximide for 90 min, the rate of uridine incorporation into MT mRNA is increased approx. 2-fold (Mayo & Palmiter, 1981) . These workers concluded that the MT-I gene might be repressed by a short-lived protein. On the other hand, Friedman & Stark (1985) reported that cycloheximide (32 ,ug/ml at 2 h) had 'little' effect on the rate of transcription of human MT2 gene in neuroblastoma cells. On the basis of additional data, these workers postulated that post-transcriptional as well as transcriptional events contribute to the accumulation of MT mRNA. This conclusion is supported by our data with cycloheximide, but Received I May 1990/28 August 1990; accepted 6 September 1990 not puromycin. Our interpretation of the effect of puromycin is similar to that of Mayo & Palmiter (1981) , i.e. that the antibiotic blocks the synthesis of a rapidly degraded repressor protein and thus stimulates transcription. We speculate that this repressor protein is normally present in large excess and that virtually complete inhibition of protein synthesis is required to obtain maximum derepression of the MT gene. The extent of inhibition of protein synthesis by cycloheximide is not sufficient, even at very high concentrations, to decrease the level of the repressor enough to obtain significant and consistent derepression; cycloheximide has its major effect on MT mRNA level by stabilization. More recently, Sadhu & Gedamu (1989) reported metal-specific differences in the rate of decline of MT mRNA in human hepatoblastoma cells (HepG2) treated with copper or zinc. They suggested that the decreased zinc-induced MT mRNA half-life is probably due to a post-transcriptional event(s).
The present study examined the effect of inhibiting protein synthesis on the expression of the MT gene in chicken hepatocytes. The inhibition of protein synthesis (by several inhibitors) resulted in the accumulation of MT mRNA. Investigation into a possible mechanism indicated that cycloheximide decreased MT mRNA degradation, whereas puromycin stimulated transcription. These contrasting effects may be related to the potency of antibiotic action. Our data highlight the importance of using more than one protein-synthesis inhibitor when studying the role of protein synthesis in gene expression.
